Education May Affect β-Amyloid Burden in Alzheimer Disease
WEDNESDAY, Aug. 5, 2020 -- Years of education and the ε4 risk allele at APOE influence β-amyloid pathology in asymptomatic individuals with a parental history of sporadic Alzheimer disease (AD), while only years of education influence β-amyloid pathology in presymptomatic autosomal dominant AD mutation carriers, according to a study published online Aug. 5 in Neurology.
Julie Gonneaud, Ph.D., from McGill University in Montreal, and colleagues analyzed cross-sectional data from 106 asymptomatic individuals with a parental history of sporadic AD and 117 presymptomatic autosomal dominant AD mutation carriers. The influence of years of education, APOE-ε4 status, and their interaction on β-amyloid positron emission tomography was examined in each cohort.
The researchers found that increased β-amyloid burden was associated with APOE-ε4 carriage and a lower level of education for asymptomatic individuals with a parental history of sporadic AD; no interaction was seen between these. There was no relation between APOE-ε4 and β-amyloid burden among presymptomatic mutation carriers of autosomal dominant AD; however, increasing level of education was associated with decreased β-amyloid burden. In the two cohorts, there was a similar association between educational attainment and β-amyloid burden.
"These results add to the growing literature suggesting that preventive strategies targeting environmental/modifiable risk factors could prevent, or at least delay, AD cases," the authors write.
© 2020 HealthDay. All rights reserved.
Posted: August 2020
Read this next
THURSDAY, Sept. 24, 2020 -- Supplements marketed to improve memory and cognitive function frequently contain unapproved drugs, often at supratherapeutic dosages, according to a...
WEDNESDAY, Sept. 23, 2020 -- For older adults with type 2 diabetes, cognitive decline is slower and dementia risk reduced for those receiving metformin, according to a study...
MONDAY, Sept. 21, 2020 -- There is an inverted U-shaped association between sleep duration and global cognitive decline, according to a study published online Sept. 21 in JAMA...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.